Combination Chemotherapy and Donor Stem Cell Transplant Followed by Ixazomib Citrate Maintenance Therapy in Treating Patients With Relapsed High-Risk Multiple Myeloma
Clinical trial NCT02504359 · COMPLETED
Trial details
- NCT number
- NCT02504359
- Sponsor
- OHSU Knight Cancer Institute
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2015-07-20
- Primary completion
- 2020-09-09
- Enrollment
- 11
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.